Daraasad cusub oo bukaan-socod bini-aadmi ah waxay isticmaashaa tayo sare leh, laga soosaaray ashwagandha patented, Witholytin, si loo qiimeeyo saamaynta togan ee daalka iyo walbahaarka.
Cilmi-baadhayaashu waxay qiimeeyeen badbaadada ashwagandha iyo saamaynta ay ku leedahay daalka la dareemayo iyo walbahaarka 111 rag iyo dumar caafimaad qaba oo da'doodu u dhaxayso 40-75 sano kuwaas oo la kulmay heerar tamar hooseeya iyo walbahaarka dhexdhexaad ah ilaa heer sare ah oo la dareemay muddo 12-usbuuc ah. Daraasadu waxay isticmaashay qiyaasta 200 mg ee ashwagandha laba jeer maalintii.
Natiijooyinku waxay muujiyeen in ka qaybgalayaasha qaatay ashwagandha ay la kulmeen hoos u dhac weyn oo ah 45.81% ee buundooyinka caalamiga ah ee Chalder Fatigue Scale (CFS) iyo 38.59% hoos u dhaca diiqada .
Natiijooyinka kale waxay muujiyeen in buundooyinka jireed ee Nidaamka Macluumaadka Qiyaasta Natiijooyinka Warbixinta Bukaanka (PROMIS-29) ay kordheen (la hagaajiyay) 11.41%, buundooyinka cilmi nafsiga ee PROMIS-29 (la hagaajiyay) hoos u dhacay 26.30% oo kordhay 9 .1% marka loo eego placebo . Kala duwanaanshaha garaaca wadnaha (HRV) ayaa hoos u dhacay 18.8%.
Gabagabada daraasaddan waxay muujineysaa in ashwagandha ay awood u leedahay inay taageerto habka la qabsiga, la dagaalanka daalka, dib u soo kabashada, iyo kor u qaadida homeostasis iyo dheelitirka.
Cilmi-baarayaasha ku lug leh daraasaddan waxay sheeganayaan in ashwagandha ay faa'iidooyin tamarsiineed oo muhiim ah u leedahay dadka da'da dhexe iyo kuwa ka weyn ee cayilan ee la kulma heerarka sare ee walbahaarka iyo daalka.
Baadhitaan hoose ayaa la sameeyay si loo baaro biomarkers hormoonnada ka qaybgalayaasha ragga iyo dumarka. Heerarka dhiigga ee testosterone bilaashka ah (p = 0.048) iyo hormoonka luteining (p = 0.002) ayaa si weyn u kordhay 12.87% ragga qaata ashwagandha marka la barbardhigo kooxda placebo.
Marka la eego natiijooyinkaan, waxaa muhiim ah in la sii baaro kooxaha tirakoobka ee laga yaabo inay ka faa'iideystaan ​​​​qaadashada ashwagandha, maaddaama saameynteeda yareynta walaaca ay ku xiran tahay arrimo ay ka mid yihiin da'da, jinsiga, heerka index mass index, iyo doorsoomayaasha kale.
"Waxaan ku faraxsannahay in daabacaadan cusubi ay ku darayso caddaynta taageeraya Vitolitin iyo caddaynteena sii kordheysa ee caddaynaysa halbeegga USP ee soosaarka ashwagandha," ayuu yiri Sonya Cropper, madaxweyne ku xigeenka fulinta ee Verdure Sciences. Cropper ayaa sii wadata, "Waxaa jira xiisaha sii kordhaya ee ashwagandha, adaptogens, daal, tamarta iyo waxqabadka maskaxda."
Vitolitin waxaa soo saaray Sayniska Verdure waxaana Yurub u qaybiya LEHVOSS Nutrition, qayb ka mid ah Kooxda LEHVOSS.